05: The Future of Psychedelics in Healthcare

Judith Warner speaks with Dr. Matthew Johnson about the state of psychedelic research today and the likelihood that certain drugs — MDMA and psilocybin specifically — could soon be approved for the treatment of conditions like addiction and PTSD. Psychedelics have long been known for their abilities to alter perception, but renewed interest by major research institutions in psychedelics’ ability to treat a range of common disorders has brought some of them to the precipice of FDA approval. DR. JOHNSON is a professor of Psychiatry and Behavioral Sciences at Johns Hopkins University and a leader in the study of psychedelics for the treatment of addiction. A transcript of their conversation can be found at Aventine.org/podcast. To learn more about listener data and our privacy practices visit: https://www.audacyinc.com/privacy-policy Learn more about your ad choices. Visit https://podcastchoices.com/adchoices

Om Podcasten

Whether you’re aware of it or not, you are part of one of the most ambitious projects we as humans have ever attempted: Rebuilding the world, pretty much from the ground up, in order to switch from fossil fuels to clean energy sources. It’s a major undertaking, one that will require staggering financial investment and the success of technologies many people have never heard of. In this season of The World as You'll Know It, science journalist Arielle Duhaime-Ross goes deep inside the world of cutting-edge climate technologies and asks: How is this all going to work? The answers — from some of the world’s most innovative and audacious thinkers, builders and investors — reveal the promise, obstacles and tradeoffs of a new clean-energy landscape that will shape the way we live.